Australia and New Zealand move closer
This article was originally published in Clinica
A Trans-Tasman liaison group has been set up to pursue closer cooperation between Australia and New Zealand on trade in therapeutic goods, including medical devices. This sector was given a temporary exemption - until May 1999 - from the 1996 Trans-Tasman Mutual Recognition Agreement in order to allow cooperation programmes on device and pharmaceutical regulation to be undertaken between the two countries.
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.